First experience with osimertinib in patients with T790M mutation previously treated with EGFR-TKIs in Croatia

Category Primary study
JournalJournal of Clinical Oncology
Year 2017
This article has no abstract
Epistemonikos ID: d1f37cec31c6aaa0029e7d173609cbae944053e6
First added on: Feb 08, 2025